| Chronic Obstructive Pulmonary Disease |
1 |
1 |
| Beta Blockers |
0 |
0.99 |
| Severe COPD |
0 |
0.41 |
| Washington DC |
0 |
0.29 |
| Cardiovascular disease |
0 |
0.28 |
| Heart |
0 |
0.28 |
| Hospital |
0 |
0.28 |
| Physiology |
0 |
0.28 |
| Washington |
0 |
0.28 |
| Evidence-Based Medicine |
0 |
0.23 |
| Cardiovascular Risk Management |
0 |
0.2 |
| Acute Myocardial Infarction (MI) |
0 |
0.19 |
| Airway |
0 |
0.14 |
| Fellowship |
0 |
0.14 |
| Infarction |
0 |
0.14 |
| Lung |
0 |
0.14 |
| Maryland |
0 |
0.14 |
| Receptors |
0 |
0.14 |
| Residency |
0 |
0.14 |
| Sleep |
0 |
0.14 |
| Statistics |
0 |
0.14 |
| Students |
0 |
0.14 |
| Weakness |
0 |
0.14 |
| Neuroendocrine Tumor |
0 |
0.1 |
| Myocardial Infarction (MI) |
0 |
0.09 |